Grifols, S.A. (GIFLF)
OTCMKTS
· Delayed Price · Currency is USD
11.45
0.00 (0.00%)
Jun 25, 2025, 8:00 PM EDT
Grifols Revenue
Grifols had revenue of 1.79B EUR in the quarter ending March 31, 2025, with 9.85% growth. This brings the company's revenue in the last twelve months to 7.37B, up 10.76% year-over-year. In the year 2024, Grifols had annual revenue of 7.21B with 9.41% growth.
Revenue (ttm)
7.37B EUR
Revenue Growth
+10.76%
P/S Ratio
0.93
Revenue / Employee
309.34K EUR
Employees
23,833
Market Cap
7.41B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.21B | 620.41M | 9.41% |
Dec 31, 2023 | 6.59B | 528.01M | 8.71% |
Jan 1, 2023 | 6.06B | 1.13B | 22.92% |
Dec 31, 2021 | 4.93B | -406.92M | -7.62% |
Dec 31, 2020 | 5.34B | 241.35M | 4.73% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Elite Pharmaceuticals | 70.00M |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Grifols News
- 20 days ago - XL-protein grants worldwide license to Grifols to develop a biopharmaceutical using PASylation® technology - GlobeNewsWire
- 4 weeks ago - Mason Capital Management to Support Grifols Recommended Director Slate at Upcoming Ordinary General Meeting - Business Wire
- 4 weeks ago - Grifols lawsuit against Gotham City to proceed after New York court ruling - Seeking Alpha
- 4 weeks ago - US court finds enough evidence to proceed with Grifols lawsuit against Gotham City - Reuters
- 5 weeks ago - Grifols: If This Works Out, It Has Massive Upside - Seeking Alpha
- 6 weeks ago - Grifols S.A. reports Q1 results - Seeking Alpha
- 6 weeks ago - Grifols, S.A. (GRFS) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 6 weeks ago - Grifols says on course to meet 2025 outlook as net profit triples - Reuters